These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 17355298
21. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?]. Martinez de Tejada B, Othenin-Girard V, Irion O. Rev Med Suisse; 2015 Oct 28; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179 [Abstract] [Full Text] [Related]
22. [Prevention of preterm delivery with gestagens]. Schindler AE. Z Geburtshilfe Neonatol; 2004 Oct 28; 208(5):165-9. PubMed ID: 15508049 [Abstract] [Full Text] [Related]
23. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Borna S, Sahabi N. Aust N Z J Obstet Gynaecol; 2008 Feb 28; 48(1):58-63. PubMed ID: 18275573 [Abstract] [Full Text] [Related]
24. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey. Ness A, Dias T, Damus K, Burd I, Berghella V. Am J Obstet Gynecol; 2006 Oct 28; 195(4):1174-9. PubMed ID: 17000251 [Abstract] [Full Text] [Related]
25. South Australian rural women's views of their pregnancy, birthing and postnatal care. Guest ML, Stamp GE. Rural Remote Health; 2009 Oct 28; 9(3):1101. PubMed ID: 19621980 [Abstract] [Full Text] [Related]
26. An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section. Mockler JC, Murphy DJ, Wallace EM. Aust N Z J Obstet Gynaecol; 2010 Feb 28; 50(1):30-5. PubMed ID: 20218994 [Abstract] [Full Text] [Related]
28. Does progesterone treatment influence risk factors for recurrent preterm delivery? Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S. Obstet Gynecol; 2005 Sep 28; 106(3):557-61. PubMed ID: 16135587 [Abstract] [Full Text] [Related]
29. [Prevention of preterm delivery: new interventions]. Boulvain M, de Tejada BM, Qayoom Z, Pfister R, Palacio-Espasa F, Irion O. Rev Med Suisse; 2006 Oct 25; 2(84):2396-8, 2400. PubMed ID: 17121246 [Abstract] [Full Text] [Related]
30. Use of progesterone treatment for the prevention of recurrent preterm birth: identification of obstacles to change. Lim AC, Goossens A, Ravelli AC, Boer K, Bruinse HW, Mol BW. Am J Perinatol; 2010 Mar 25; 27(3):241-9. PubMed ID: 19823963 [Abstract] [Full Text] [Related]
33. Primiparity: an 'intermediate' risk group for spontaneous and medically indicated preterm birth. Ananth CV, Peltier MR, Getahun D, Kirby RS, Vintzileos AM. J Matern Fetal Neonatal Med; 2007 Aug 25; 20(8):605-11. PubMed ID: 17674278 [Abstract] [Full Text] [Related]
34. Vaginal progesterone to prevent preterm birth in high-risk women. Fontenot HB, Fantasia HC. Nurs Womens Health; 2012 Aug 25; 16(3):237-41. PubMed ID: 22697227 [Abstract] [Full Text] [Related]
35. Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis. Eddama O, Petrou S, Regier D, Norrie J, MacLennan G, Mackenzie F, Norman JE. Int J Technol Assess Health Care; 2010 Apr 25; 26(2):141-8. PubMed ID: 20392316 [Abstract] [Full Text] [Related]
37. Recruitment to research studies in maternity hospitals: an example from the Early Births Study. Watson LF, Lumley J, Rayner JA, Potter A. Midwifery; 2008 Dec 25; 24(4):509-20. PubMed ID: 17950504 [Abstract] [Full Text] [Related]
38. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The FOREMOST Trial). East CE, Chan FY, Brennecke SP, King JF, Colditz PB. Birth; 2006 Jun 25; 33(2):101-9. PubMed ID: 16732774 [Abstract] [Full Text] [Related]